Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid ...
The reputable scientific journal, The Lancet Regional Health - Europe, has published robust results from ALK's house dust mite sublingual allergy immunotherapy tablet (SLIT-tablet) phase 3 children ...